About
Company Overview
Management
Board of Directors
Advisory Board
Collaborations
Partner Collaborations
Scientific & Research Collaborations
Patients
Patients Overview
About Clinical Studies
Current Studies
Sponsored
TakeAim Lymphoma
TakeAim Leukemia
Compassionate Use Policy
Pipeline
Pipeline Overview
Emavusertib
(CA-4948)
Fimepinostat
CA-170
CA-327
Erivedge
®
Scientific Resources
Investors
Overview
Press Releases
Events and Presentations
Corporate Governance
Committee Composition
Contact the Board
Financial Information
SEC Filings
Annual Reports
IRS Form 8937
Stock Performance
Interactive Chart
Historical Stock Lookup
Analyst Coverage
Contact Us
Careers
Life at Curis
Open Positions
Benefits
Contact
About
Company Overview
Management
Board of Directors
Advisory Board
Collaborations
Partner Collaborations
Scientific & Research Collaborations
Patients
Patients Overview
About Clinical Studies
Current Studies
Sponsored
TakeAim Lymphoma
TakeAim Leukemia
Compassionate Use Policy
Pipeline
Pipeline Overview
Emavusertib
(CA-4948)
Fimepinostat
CA-170
CA-327
Erivedge
®
Scientific Resources
Investors
Overview
Press Releases
Events and Presentations
Corporate Governance
Committee Composition
Contact the Board
Financial Information
SEC Filings
Annual Reports
IRS Form 8937
Stock Performance
Interactive Chart
Historical Stock Lookup
Analyst Coverage
Contact Us
Careers
Life at Curis
Open Positions
Benefits
Contact
Management
Rachel Blasbalg »
Senior Director, Human Resources
James Dentzer »
President & CEO
Diantha Duvall »
Chief Financial Officer
Dora Ferrari »
Vice President, Clinical Operations
Robert Martell, M.D., Ph.D. »
Chief Scientific Officer
Mark Noel »
Vice President, Technology Management & Intellectual Property
Nancy Soohoo »
Vice President & General Counsel
Jonathan Zung, Ph.D. »
Chief Development Officer
1
About
Company Overview
Management
Board of Directors
Advisory Board
Collaborations
Partner Collaborations
Scientific & Research Collaborations
Patients
Patients Overview
About Clinical Studies
Current Studies
Sponsored
TakeAim Lymphoma
TakeAim Leukemia
Compassionate Use Policy
Pipeline
Pipeline Overview
Emavusertib
(CA-4948)
Fimepinostat
CA-170
CA-327
Erivedge
®
Scientific Resources
Investors
Overview
Press Releases
Events and Presentations
Corporate Governance
Committee Composition
Contact the Board
Financial Information
SEC Filings
Annual Reports
IRS Form 8937
Stock Performance
Interactive Chart
Historical Stock Lookup
Analyst Coverage
Contact Us
Careers
Life at Curis
Open Positions
Benefits
Contact